Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Gene Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Gene Therapy Market, by vector, 2019-2029 (USD Billion)
1.2.3. Gene Therapy Market, by Delivery Method, 2019-2029 (USD Billion)
1.2.4. Gene Therapy Market, by Application, 2019-2029 (USD Billion)
1.2.5. Gene Therapy Market, by Gene Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gene Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gene Therapy Market Dynamics
3.1. Gene Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Globally rising rates of Cancer and Genetic Diseases
3.1.1.2. Increasing Investment by major Market Players
3.1.2. Market Challenges
3.1.2.1. High Cost of Gene Therapy
3.1.3. Market Opportunities
3.1.3.1. Research and Development of Gene Therapy
Chapter 4. Global Gene Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Gene Therapy Market, by vector
6.1. Market Snapshot
6.2. Global Gene Therapy Market by vector, Performance – Potential Analysis
6.3. Global Gene Therapy Market Estimates & Forecasts by vector 2019-2029 (USD Billion)
6.4. Gene Therapy Market, Sub Segment Analysis
6.4.1. Viral Vectors
6.4.2. Non-viral Vectors
Chapter 7. Global Gene Therapy Market, by Delivery Method
7.1. Market Snapshot
7.2. Global Gene Therapy Market by Delivery Method, Performance – Potential Analysis
7.3. Global Gene Therapy Market Estimates & Forecasts by Delivery Method 2019-2029 (USD Billion)
7.4. Gene Therapy Market, Sub Segment Analysis
7.4.1. In Vivo
7.4.2. Ex Vivo
Chapter 8. Global Gene Therapy Market, by Application
8.1. Market Snapshot
8.2. Global Gene Therapy Market by Application, Performance – Potential Analysis
8.3. Global Gene Therapy Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Gene Therapy Market, Sub Segment Analysis
8.4.1. Oncological Disorders
8.4.2. Rare Diseases
8.4.3. Cardiovascular Diseases
8.4.4. Neurological Disorders
8.4.5. Infectious Diseases
8.4.6. Others
Chapter 9. Global Gene Therapy Market, by Gene Type
9.1. Market Snapshot
9.2. Global Gene Therapy Market by Gene Type, Performance – Potential Analysis
9.3. Global Gene Therapy Market Estimates & Forecasts by Gene Type 2019-2029 (USD Billion)
9.4. Gene Therapy Market, Sub Segment Analysis
9.4.1. Antigen
9.4.2. Cytokine
9.4.3. Tumor Suppressor
9.4.4. Suicide
9.4.5. Deficiency
9.4.6. Receptors
9.4.7. Others
Chapter 10. Global Gene Therapy Market, Regional Analysis
10.1. Gene Therapy Market, Regional Market Snapshot
10.2. North America Gene Therapy Market
10.2.1. U.S. Gene Therapy Market
10.2.1.1. vector breakdown estimates & forecasts, 2019-2029
10.2.1.2. Delivery Method breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. Gene Type breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Gene Therapy Market
10.3. Europe Gene Therapy Market Snapshot
10.3.1. U.K. Gene Therapy Market
10.3.2. Germany Gene Therapy Market
10.3.3. France Gene Therapy Market
10.3.4. Spain Gene Therapy Market
10.3.5. Italy Gene Therapy Market
10.3.6. Rest of Europe Gene Therapy Market
10.4. Asia-Pacific Gene Therapy Market Snapshot
10.4.1. China Gene Therapy Market
10.4.2. India Gene Therapy Market
10.4.3. Japan Gene Therapy Market
10.4.4. Australia Gene Therapy Market
10.4.5. South Korea Gene Therapy Market
10.4.6. Rest of Asia Pacific Gene Therapy Market
10.5. Latin America Gene Therapy Market Snapshot
10.5.1. Brazil Gene Therapy Market
10.5.2. Mexico Gene Therapy Market
10.6. Rest of The World Gene Therapy Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Amgen Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Biogen Inc.
11.2.3. Bluebird Bio Inc.
11.2.4. Gilead Sciences Inc. (Kite Pharma)
11.2.5. Novartis AG
11.2.6. Orchard Therapeutics
11.2.7. Sibiono GeneTech Co. Ltd
11.2.8. Hoffmann-La Roche Ltd (Spark Therapeutics)
11.2.9. UniQure NV
11.2.10. Abeona Therapeutics Inc
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
